Abstract
Endometrial carcinoma is the second most common gynecologic cancer worldwide. Hyperplasia is aprecursor to endometrioid adenocarcinoma. There are few studies on the association of HPV with endometrialadenocarcinoma.Aim of the Study: To determine the relation of HPV with premalignant and malignant endometrial lesions.Patients and Method: This study achieved on a total number of 90 patients with histopathologicalexamination revealing endometrial hyperplasia in 30 patient, endometrial carcinoma in 30 patient in additionto 30 cases who underwent hystrectomy, for all patients detection of HR-HPV done by RT-PCR.Results: The HR-HPV positivity was recorded in 23 patients. For the studied cases with endometrialcarcinoma, endometrial hyperplasia and controls the positivity rates were about (16.7%), (36.7%) and(23.3%) respectively. Highest rate of HR-HPV positivity for the studied patients was found in the age group(45-49). Highest rate of HR-HPV positivity in cases with endometrial carcinoma was reported in older agegroups [(45-49) and (50-54)], compared to endometrial hyperplasia and controls [(40-44) and (45-49)]. TheHR-HPV positivity was most frequently observed in cases with well-differentiated (22.2%). Higher HRHPV positivity rate was reported in the hyperplasia without atypia.Conclusion: No role of HR-HPV in the pathogenesis of endometrial carcinoma.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call